Shares of Loblaw Companies Limited (TSE:L – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven research firms that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is C$197.00.
A number of analysts have recently issued reports on the stock. CIBC raised their price target on shares of Loblaw Companies from C$189.00 to C$206.00 in a report on Thursday, November 14th. TD Securities dropped their target price on shares of Loblaw Companies from C$203.00 to C$202.00 and set a “buy” rating on the stock in a report on Thursday, November 14th. Desjardins boosted their target price on shares of Loblaw Companies from C$172.00 to C$190.00 in a research note on Thursday, November 14th. National Bankshares boosted their price target on Loblaw Companies from C$188.00 to C$195.00 in a research note on Thursday, November 14th. Finally, UBS Group set a C$225.00 price objective on shares of Loblaw Companies and gave the stock a “buy” rating in a research note on Friday.
Get Our Latest Stock Report on L
Loblaw Companies Stock Performance
Loblaw Companies Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, December 30th. Investors of record on Monday, December 30th will be issued a dividend of $0.513 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.05 annualized dividend and a yield of 1.06%. Loblaw Companies’s payout ratio is presently 31.06%.
About Loblaw Companies
Loblaw is one of Canada’s largest grocery, pharmacy, and general merchandise retailers, operating the most expansive store footprint in Ontario and maintaining sizable presences in provinces like Quebec and British Columbia. Key grocery banners include Loblaw, No Frills, and Maxi, while its pharmaceutical operations are the product of its 2014 acquisition of Shoppers Drug Mart.
Featured Stories
- Five stocks we like better than Loblaw Companies
- The Most Important Warren Buffett Stock for Investors: His Own
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Where to Find Earnings Call Transcripts
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.